Kestra Medical Technologies (KMTS) Change in Receivables (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Change in Receivables data on file, last reported at $2.7 million in Q1 2026.

• Change in Receivables for Q1 2026 came in at $2.7 million, down 20.42% year-over-year; the trailing twelve-month figure through Jan 2026 was $7.1 million (down 20.3% YoY), and the FY2025 annual result was $8.8 million, up 251.36% from the prior year.
• Change in Receivables climbed to $2.7 million in Q1 2026 per KMTS's latest filing, from $1.7 million in the prior quarter.
• Over five years, Change in Receivables peaked at $3.3 million in Q1 2025 and troughed at $963000.0 in Q2 2025.
• A 3-year average of $2.0 million and a median of $1.7 million in 2025 frame the typical range for Change in Receivables.
• On a YoY basis, Change in Receivables climbed as much as 7.91% in 2025 and fell as far as 38.51% in 2025.
• A 3-year view of Change in Receivables shows it stood at $1.6 million in 2024, then gained by 7.91% to $1.7 million in 2025, then surged by 56.07% to $2.7 million in 2026.
• Business Quant data shows KMTS's Change in Receivables at $2.7 million in Q1 2026, $1.7 million in Q4 2025, and $1.8 million in Q3 2025.